Medication Safety Issues
Sound-alike/look-alike issues:
Larotrectinib may be confused with alectinib, entrectinib, lapatinib, lenvatinib, lonafarnib, lorlatinib.
High alert medication:
The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drug classes (chemotherapeutic agent, parenteral and oral) which have a heightened risk of causing significant patient harm when used in error (High-Alert Medications in Acute Care, Community/Ambulatory Care, and Long-Term Care Settings).
